Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001099800-23-000015
Filing Date
2023-03-28
Accepted
2023-03-28 16:18:02
Documents
12

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2023proxysupplement-sto.htm DEFA14A 15235
2 GRAPHIC a2023proxysupplement-sto001.jpg GRAPHIC 50386
3 GRAPHIC a2023proxysupplement-sto002.jpg GRAPHIC 164490
4 GRAPHIC a2023proxysupplement-sto003.jpg GRAPHIC 110322
5 GRAPHIC a2023proxysupplement-sto004.jpg GRAPHIC 137226
6 GRAPHIC a2023proxysupplement-sto005.jpg GRAPHIC 116827
7 GRAPHIC a2023proxysupplement-sto006.jpg GRAPHIC 122728
8 GRAPHIC a2023proxysupplement-sto007.jpg GRAPHIC 185556
9 GRAPHIC a2023proxysupplement-sto008.jpg GRAPHIC 179196
10 GRAPHIC a2023proxysupplement-sto009.jpg GRAPHIC 185912
11 GRAPHIC a2023proxysupplement-sto010.jpg GRAPHIC 144456
12 GRAPHIC a2023proxysupplement-sto011.jpg GRAPHIC 167789
  Complete submission text file 0001099800-23-000015.txt   2172879
Mailing Address ONE EDWARDS WAY IRVINE CA 92614
Business Address ONE EDWARDS WAY IRVINE CA 92614 9492502500
Edwards Lifesciences Corp (Filer) CIK: 0001099800 (see all company filings)

EIN.: 364316614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-15525 | Film No.: 23769816
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies